Home › Encyclopedia › Carbetocin: Research Status and Trial Data
Research / Unapproved

Carbetocin: Research Status and Trial Data

Molecular formulaC45H69N11O12S
Molecular weight988.2 g/mol
Registered trials107
PubChem CID16681432

What carbetocin is

Carbetocin is a synthetic peptide compound identified by PubChem CID 16681432, with a molecular formula of C45H69N11O12S. It does not currently carry an approved label in the available regulatory data, meaning no FDA-sanctioned indication, dosing, or safety labeling has been established from this dataset. Carbetocin remains classified here as an unapproved research compound.

Trial footprint

Carbetocin has been studied across 107 registered clinical trials. Among the sampled studies, one Phase 3 trial titled "Intramuscular Oxytocics: A Randomised Control Trial" has reached completed status. A separate Phase 4 trial, "Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery," is also listed as completed, alongside a non-phase-classified completed trial comparing intramyometrial injection approaches during myomectomy procedures.

FAQ

Is carbetocin FDA approved?
Based on the available data, carbetocin does not have an approved FDA label. It is classified as an unapproved research compound in this dataset.
What is carbetocin?
Carbetocin is a synthetic peptide compound with the molecular formula C45H69N11O12S, tracked under PubChem CID 16681432. No approved mechanism or indication is documented in the available label data.
How many clinical trials have studied carbetocin?
There are 107 registered clinical trials involving carbetocin. Sample trials include completed Phase 3 and Phase 4 studies as well as a non-phase-classified comparative study.
What kinds of studies have been done on carbetocin?
Available trial samples include comparisons with other uterotonic agents and injection techniques in surgical and obstetric contexts. These trials range from Phase 3 to Phase 4 and one study without a specified phase, and all three sampled trials are listed as completed.
Are there known side effects of carbetocin?
No adverse event report data is available in this dataset, so no side effect pattern can be summarized at this time.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 16681432 ClinicalTrials.gov trial registry NCT02216383 NCT05242783 NCT03755531

Updated 2026-11-07